Table 5.
p-value+ | ||||
---|---|---|---|---|
CONV | UTR | UCR | Overall | |
N participants with dry weight reduction | 12 | 17 | 14 | |
DBP-pre: BCM Measurement [mmHg] | 74 ± 15 | 67 ± 13 | 76 ± 20 | 0.23 |
DBP-pre: Start Intervention Phase [mmHg] | 73 ± 14 | 70 ± 15 | 85 ± 26 | 0.09 |
DBP-post: Start Intervention Phase [mmHg] | 70 ± 13 | 66 ± 13 | 75 ± 14 | 0.17 |
DBP-pre: End Intervention Phase [mmHg] | 66 ± 11 | 64 ± 11 | 76 ± 13 | 0.02 |
DBP-post: End Intervention Phase [mmHg] | 57 ± 15 | 63 ± 12 | 69 ± 14 | 0.10 |
Delta DBP-pre: Start-to-End In Ph. [mmHg] | −7 ± 11 | −5 ± 12 | −8 ± 31 | 0.10 |
Delta DBP-post: Start-to-End In Ph. [mmHg] | −12 ± 14 | −3 ± 9 | −6 ± 14 | 0.14 |
CONV conventional hemodialysis, UTR ultrafiltration and temperature regulation, UCR ultrafiltration and dialysate conductivity regulation, N number, ECV extracellular volume, SBP systolic blood pressure, DBP diastolic blood pressure, BCM body composition monitor
PP analysis. + P-values between groups determined by two-tailed t-test, and Mann-Whitney U test. Overall p-values determined by analysis of variance and analysis of covariance (for comparison of repeated measures). In one patient from the UTR group only absolute fluid overload values could be measured; relative fluid overload values could not be calculated by the BCM device due to technical issues, resulting in deviation of the FO value from ECV